Selective estrogen receptor modulators (SERMs) are compounds that act on the estrogen receptors (ERs). This library comprises drug-like compounds only (PAINS compounds are filtered off) and provide an excellent basis for drug discovery projects related with ERs.
Selective estrogen receptor modulators (SERMs) are compounds that act on the estrogen receptors (ERs). A characteristic that distinguishes these substances from pure ER antagonists and agonists (silent antagonists and full agonists) is that their action is different in various tissues, thereby granting the possibility to selectively inhibit or stimulate estrogen-like action in various tissues.
SERMs have significant therapeutic potential and are used for various treatment estrogen-related diseases, such as ovulatory dysfunction, postmenopausal osteoporosis, breast cancer, dyspareunia due to menopause and other. OTAVAchemicals offers Selective Estrogen Receptor Modulators-Like Library.
This special sets of compounds have been carefully designed with combined approach that includes application of pharmacophore screening and Bayesian modeling. Training sets were formed based on known SERMs and used for optimization and validation of ligand-based pharmacophore models (including excluded volumes) and for Bayesian modeling. OTAVAchemicals drug-like compound Collection was screened against the best optimized pharmacophore models. Results were rescored using special weighted rescoring function, filtered based on score calculated during rescoring, and visually analyzed. Also compounds were selected with Bayesian modeling. Bayesian models were based on molecular descriptors, such as ECFP4, FCFP4, molecular weight LogP, number of hydrogen acceptors and donors, number of rotatable bonds, number of rings and molecular polar surface area.
The designed library comprises drug-like compounds only (PAINS compounds are filtered off) and provide an excellent basis for drug discovery projects related with ERs.
Otava Institute is a global provider of one-stop integrated research solutions for business and life science. Our team includes chemists, biologists, physicists whose combined efforts contribute to the complex contract research projects for pharmaceutical, agro, cosmetic and material science industries.We are dedicated to providing clients with outstanding service in these key areas and will continue to push boundaries to remain an industry front-runner. Each day we expand our core competencies delivering of new technologies to meet all the customer’s needs.
Our location in Toronto Ontario, Canada provides our clients with the added advantage of North American IP rules and regulations and secure communication and logistics. Our Ukraine – based R&D facilities represented with the Ukrainian Laboratories, that is cooperating with leading Ukrainian research institutions and carries out research work in the format of outsourcing.
We work as a preferred partner to many of the world’s top 10 pharma firms, and hundreds of other companies, providing support with creative solutions for complex technical compound issues. Our scientific knowledge, combined with our research and manufacturing capability, enables us to support chemical processing and production without ever compromising on quality.
Our experience, dedication, and commitment to quality make us an ideal partner for discovery stage research.
Create your free account to connect with Taras Maiula and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Taras
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
